
|Articles|October 23, 2016
Hepatitis C Drug Cost Variance Highlights AJPB Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Vaccine Mandates During COVID-19 Did Not Raise Vaccination Rates, New Study Finds
2
FDA Approves Reformulated Ranitidine After 5-Year Absence
3
Navigating Migraine Management and the Role of Symbravo in Acute Treatment
4
FDA Approves Enfortumab Vedotin Plus Pembrolizumab for Muscle-Invasive Bladder Cancer
5
























































































































































































































